Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice

Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice

Published on Oct 21
3分钟
Project Oncology®
0:00
0:00
<article data-scroll-anchor="false" data-testid="conversation-turn-2" data-turn="assistant" data-turn-id="request-WEB:9a0e8cf0-e2a6-4107-b62a-50d38949b847-1" dir="auto" tabindex="-1"> <div> <div tabindex="-1"> <div> <div data-message-author-role="assistant" data-message-id="034d0249-5b25-4b56-8dd6-7bab383bdc4a" data-message-model-slug="gpt-5" dir="auto"> <div> <div> <p data-end="723" data-is-last-node="" data-is-only-node="" data-start="116">As medicine shifts toward race-neutral lung function interpretation, new challenges emerge in ensuring equitable access to care. Dr. Ajay Sheshadri explores how race-neutral spirometry may impact patient selection for lung resection surgery and hematopoietic cell transplantation. Dr. Sheshadri is an Associate Professor in the Department of Pulmonary Medicine at the University of Texas MD Anderson Cancer Center.</p> </div> </div> </div> </div> </div> </div> </article>